menu
    • menu

    Company profile for Celldex Therapeutics

    NEW Drugs in Dev: 25
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Celldex TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    53 Frontage Road, Suite 220 Hampton, NJ 08827
    Telephone
    Telephone
    (908) 454-7120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://celldex.com/
    Linkedin
    Linkedin
    http://www.linkedin.com/company/597166
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/search?q=celldex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celldex Announces Proposed Public Offering Of Common Stock
    Celldex Announces Proposed Public Offering Of Common Stock

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266968/24180/en/Celldex-Announces-Proposed-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Celldex Shows Ph2 Urticaria QoL Gains At AAD 2026
    Celldex Shows Ph2 Urticaria QoL Gains At AAD 2026

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263841/24180/en/Celldex-Presents-Positive-Data-from-Phase-2-Chronic-Spontaneous-Urticaria-and-Phase-2-Cold-Urticaria-and-Symptomatic-Dermographism-Studies-Demonstrating-Rapid-Profound-and-Durable-.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Celldex Presents Data from Phase 2 Chronic Spontaneous Urticaria
    Celldex Presents Data from Phase 2 Chronic Spontaneous Urticaria

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246759/24180/en/Celldex-Presents-Additional-Positive-Data-from-Phase-2-Chronic-Spontaneous-Urticaria-CSU-and-Phase-2-Cold-Urticaria-ColdU-and-Symptomatic-Dermographism-SD-Studies-Further-Demonstra.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Celldex Finishes Global Ph 3 Enrollment For Barzolvolimab in CSU
    Celldex Finishes Global Ph 3 Enrollment For Barzolvolimab in CSU

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244485/24180/en/Celldex-Completes-Enrollment-in-Global-Phase-3-Studies-EMBARQ-CSU1-and-EMBARQ-CSU2-of-Barzolvolimab-in-Chronic-Spontaneous-Urticaria.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Celldex Unveils 2025 Financials And Corporate Progress
    Celldex Unveils 2025 Financials And Corporate Progress

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244966/24180/en/Celldex-Reports-Fourth-Quarter-and-Year-End-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Celldex To Present Barzolvolimab Data At AAAAI 2026
    Celldex To Present Barzolvolimab Data At AAAAI 2026

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242604/24180/en/Celldex-Announces-Multiple-Upcoming-Presentations-at-AAAAI-2026-Supporting-Barzolvolimab-s-First-in-Class-and-Best-in-Disease-Profile.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search